Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice

  1. Chamorro-de-Vega, E.
  2. Gimenez-Manzorro, A.
  3. Rodriguez-Gonzalez, C.G.
  4. Escudero-Vilaplana, V.
  5. Collado Borrell, R.
  6. Ibañez-Garcia, S.
  7. Lallana Sainz, E.
  8. Lobato Matilla, E.
  9. Lorenzo-Pinto, A.
  10. Manrique-Rodriguez, S.
  11. Fernandez-Llamazares, C.M.
  12. Marzal-Alfaro, M.
  13. Ribed, A.
  14. Romero Jimenez, R.M.
  15. Sarobe Gonzalez, C.
  16. Herranz, A.
  17. Sanjurjo, M.
Journal:
Annals of Pharmacotherapy

ISSN: 1542-6270 1060-0280

Year of publication: 2016

Volume: 50

Issue: 11

Pages: 901-908

Type: Article

DOI: 10.1177/1060028016659306 GOOGLE SCHOLAR

Sustainable development goals